Condition: Diabetes · Sponsor: Midhat H. Abdulreda
The intervention in this trial is intraocular islet transplantation. A single dose of 1000 - 3000 Islet Equivalents (IEQ)/kg recipient body weight (BW) will be infused into the anterior chamber of the eye through a self-sealing incision in the peripheral cornea. The procedure is projected to take approximately 20-30 minutes. Transplant recipients in this study will receive localized maintenance immunosuppression via topical application of eye-drops.
This description comes directly from the study's public registry record.
Midhat H Abdulreda, Ph.D. · 305-243-9871 · mabdulreda@miami.edu
Sonia Yoo, M.D. · 305-326-6000 · syoo@med.miami.edu
Always discuss trial participation with your own doctor first.
| Bascom Palmer Eye Institute | Miami, Florida, United States | Recruiting |
| Diabetes Research Institute, University of Miami Miller School of Medicine | Miami, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02846571